병원감염(HAI) 대책 시장 : 제품별, 용도별, 기술별, 질환별, 최종 사용자별, 지역별 규모, 점유율 및 성장 분석과 업계 예측(2026-2033년)

Hospital-Acquired Infection Control Market size was valued at USD 32.62 Billion in 2024 and is poised to grow from USD 35 Billion in 2025 to USD 61.5 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The Hospital Acquired Infection (HAI) control market is witnessing significant growth driven by increased awareness of the importance of preventing cross-infections and the high incidence of infectious diseases in healthcare settings. Government support for infection control initiatives also plays a crucial role in enhancing market dynamics. Strict infection prevention standards and protocols established across diverse healthcare levels foster a culture centered on safety and hygiene. Furthermore, the escalating use of advanced monitoring solutions strengthens this trend, enabling healthcare facilities to implement proactive strategies for effectively preventing and managing HAIs. These combined factors underscore a growing commitment to maintaining patient safety and improving overall health outcomes within hospitals.

Top-down and bottom-up approaches were used to estimate and validate the size of the Hospital-Acquired Infection Control market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Hospital-Acquired Infection Control Market Segments Analysis

Global Hospital-Acquired Infection Control Market is segmented by Product, Application, Technology, Disease, End User and region. Based on Product, the market is segmented into Protective Barrier, Sterilization, Disinfectants, Disinfectors, Endoscope Reprocessing Products and Other Infection Control Products. Based on Application, the market is segmented into Disease Testing and Drug-Resistance Testing. Based on Technology, the market is segmented into Phenotypic Methods and Genotypic Methods. Based on Disease, the market is segmented into Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection and Others. Based on End User, the market is segmented into Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers, Nursing Homes & Maternity Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Hospital-Acquired Infection Control Market

The global Hospital-Acquired Infection Control market has seen significant growth driven by the rising number of surgical procedures performed each year, which has reached an impressive volume globally. This surge can be attributed to various factors, including the increasing incidence of health conditions such as obesity and other lifestyle-related diseases, which often require surgical treatment. As more surgeries are conducted, the associated risk of hospital-acquired infections also escalates, highlighting the critical need for effective infection control measures. Consequently, healthcare facilities are increasingly investing in advanced infection prevention solutions to enhance patient safety and improve overall outcomes.

Restraints in the Hospital-Acquired Infection Control Market

The Hospital-Acquired Infection Control market faces a challenge as healthcare providers frequently choose to reprocess reusable medical devices to cut costs and minimize waste. This practice involves a diverse array of instruments, including surgical forceps, endoscopes, and stethoscopes. Despite the financial and environmental benefits, there are ongoing concerns about the safety and effectiveness of these reprocessed instruments. Such apprehensions can lead to hesitancy among healthcare professionals and patients alike, potentially impacting the overall adoption of infection control measures within medical facilities. As a result, the perceived risks associated with reprocessing may constrain market growth and innovation in infection prevention strategies.

Market Trends of the Hospital-Acquired Infection Control Market

The market for Hospital-Acquired Infection (HAI) control is witnessing a significant trend towards the reintroduction of ethylene oxide sterilization due to its unparalleled effectiveness, particularly for temperature-sensitive medical instruments. This resurgence is driven by an increasing demand for advanced sterilization methods that maintain the integrity of delicate devices. However, the evolving landscape is marked by a growing awareness surrounding the health risks tied to ethylene oxide exposure, prompting healthcare facilities to adopt improved safety protocols and technologies. As hospitals seek to balance efficacy with safety, innovations in delivery systems and monitoring practices are expected to enhance the appeal and acceptance of ethylene oxide in infection control strategies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Hospital-Acquired Infection Control Market Size by Product & Services & CAGR (2026-2033)

• Market Overview
• Protective Barrier
• Sterilization
• Disinfectants
  • Product
  • Hand Disinfectants
  • Surface Disinfectants
  • Skin Disinfectants
  • Instrument Disinfectants
  • Formulation
  • Liquid Disinfectants
  • Disinfectant Wipes
  • Disinfectant Sprays
• Disinfectors
• Endoscope Reprocessing Products
• Other Infection Control Products

Global Hospital-Acquired Infection Control Market Size by Application & CAGR (2026-2033)

• Market Overview
• Disease Testing
• Drug-Resistance Testing

Global Hospital-Acquired Infection Control Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Phenotypic Methods
• Genotypic Methods

Global Hospital-Acquired Infection Control Market Size by Disease & CAGR (2026-2033)

• Market Overview
• Hospital Acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Urinary Tract Infection
• Others

Global Hospital-Acquired Infection Control Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & ICUs
• Ambulatory Surgical & Diagnostic Centers
• Nursing Homes & Maternity Centers
• Others

Global Hospital-Acquired Infection Control Market Size & CAGR (2026-2033)

• North America (Product & Services, Application, Technology, Disease, End User)
  • US
  • Canada
• Europe (Product & Services, Application, Technology, Disease, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Application, Technology, Disease, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Application, Technology, Disease, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Application, Technology, Disease, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• 3M Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ecolab Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Sterilization Products (ASP) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Belimed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Matachana Group (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MMM Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metrex Research LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miele Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pal International (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Melag Medizintechnik GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Contec, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDALKAN (Greece)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Systec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.B.M. S.r.l. Medical Equipment (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Continental Equipment Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGS Beta-Gamma-Service GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations